Symposium
When chronic inflammation drives fibrosis: a lesson from lung transplantation
Translational
Aims : The audience will learn about the inflammatory mechanisms that drive chronic lung allograft dysfunction (CLAD), the role that mesenchymal cells play in the pathogenesis of CLAD, how CLAD is diagnosed, and how CLAD patients are classified into different clinical phenotypes. The current CLAD prevention and treatment strategies in lung recipients will also be described.
10:45
What have we learnt regarding allospecific and aspecific inflammatory mechanisms
L. nicod(lausanne, Switzerland)
COI
1
1951
11:15
The good and the bad of mesenchymal cells in chronic lung allograft dysfunction (CLAD)
V. Lama(Ann Arbor, United States)
COI
2
1952
11:45
Different clinical phenotypes of CLAD: diagnosis and outcomes
G. Verleden(Edegem, Belgium)
COI
3
1953
12:15
Current and future preventive and treatment strategies in CLAD
A. Fisher(Newcastle-upon-Tyne, United Kingdom)
COI
4
1954
. . .
